ArrowBiome

A precise way to manage your microbiome

Employees
1–10
Business Model
B2B
Total Funding
$1.0M
Last Round
$1.0M SeedJun 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

ArrowBiome is a precision microbiome technology company that develops targeted actives designed to selectively eliminate bacteria implicated in acne and body odour while minimizing impact on the skin's healthy commensal microbiome. The company's two lead platforms — SmartArrow (a precision particle for acne) and ArcherZyme (a phage-derived enzyme targeting odour-causing bacteria like S. hominis) — have undergone gold-standard clinical validation and are commercially available for order. ArrowBiome's actives operate at ultra-low concentrations (as low as 0.01% in finished product) and are protected by a growing patent portfolio including MIT-licensed IP. The company's technology is adaptable beyond skin applications to scalp, oral, feminine, and gut microbiome use cases. ArrowBiome is actively working with global beauty multinationals and leading indie brands, with multiple commercial programmes past safety clearance and into formulation and pilot stages. The company received the in-cosmetics Asia Gold Award for its innovation.

Summary

ArrowBiome is a Biotech company. It has raised $1.0M in total across 1 round, most recently a $1.0M Seed round in Jun 2024. Investors include Cocoon Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJun 2024
$1.0M

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ArrowBiome on Indexed.vc
<a href="https://indexed.vc/companies/arrowbiome"><img src="https://indexed.vc/api/badge/company/arrowbiome" alt="ArrowBiome on Indexed.vc" width="260" height="76" /></a>